Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided thoracic paravertebral block with different nalbuphine doses for perioperative analgesia in VATS lobectomy
ChiCTR2400080491Phase 4Not yet recruiting
- Sponsor
- Taixing People's Hospital
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine in bronchial carcinoma (4 arms), sponsored by Taixing People's Hospital. Primary endpoints: Resting/Activity VAS score and Anesthesia time, intraoperative anesthetic dosage, postoperative wakefulness time, tracheal extubation time, PACU stay time. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
nalbuphine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2400080491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080491.